November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.
August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.
May 10, 2022
Research from the University of Cincinnati shows daily blueberry supplementation for certain middle-aged populations may lower the chances of developing late-life dementia.
July 28, 2022
Researchers led by the University of Cincinnati's Agnes (Yu) Luo, PhD, have published findings in the journal Cell Reports showing a novel drug helped to repair the damage caused by ischemic stroke in animal models.
June 4, 2022
The University of Cincinnati's Thomas Herzog, MD, is presenting a poster describing a new immunotherapy trial for platinum-resistant ovarian cancer, called ARTISTRY-7, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
December 5, 2022
University of Cincinnati researchers have published a new study examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.
April 14, 2023
The University of Cincinnati Cancer Center's Melinda Butsch Kovacic and colleagues will present research abstracts on several community outreach and engagement initiatives at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19.
March 29, 2023
University of Cincinnati research on the steroid dexamethasone's effect on immune cells and benefit to severe COVID-19 patients was recently published in Frontiers in Immunology.
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).
October 13, 2022
The University of Cincinnati's Jeffrey Strawn, MD, is senior author of a new editorial in JAMA discussing new recommendations that children and adolescents ages 8 to 18 should be screened for anxiety disorders.